IGFBP7 and psoriasis: The role of IGFBP7 in psoriasis is a particularly exciting discovery because IGFBP7 is thought to act on a different aspect of immune cell trafficking compared with the targets of similar existing therapies, efalizumab, natalizumab, and vedolizumab (6).